Komodo Health, which aggregates real-world evidence, has acquired market-access intel firm Breakaway Partners.

The addition further bolsters Komodo’s data offering. Similarly, having Breakaway Partners in the fold should help Komodo create a comprehensive view of real-world outcomes and costs, the firms said in a statement. Terms were not disclosed.

Market-access analytics have become more important given the shift to value-based payment models, which incentivize the use of the most effective therapies.

“In a value-driven world, payers, providers and life sciences companies need faster, more complete insights to bridge the gap between new breakthroughs, the potential impact on patient outcomes, and formulary decisions,” said Web Sun, president and co-founder of Komodo, in the statement.

Breakaway Partners’ software makes it possible to inform value-driven strategies by tracking the impact of policy and formulary decisions on patient outcomes. 

“It will now be possible to quickly understand and prioritize patient access based not only on the current landscape of existing policy restrictions, but also on the real-world experience of individual patients,” said Christian Pinsonault, managing partner at Breakaway Partners.